Stock Analysis
CVE (CVE) Stock Analysis
CVE (CVE) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
CVE (CVE) currently has an AIQ Score of 55/100, indicating a neutral setup. Value is the strongest factor at 57/100. Risk is the weakest current factor at 52/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
CVE at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $32.73 |
| AIQ Score | 55/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Neutral |
| Market Cap | $61.1B |
| P/E Ratio (TTM) | 12.77 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $1.55 |
| Revenue (quarter ended 2026-06-30) | $17.43B |
| Dividend Yield (TTM) | 1.78% |
| Beta | 0.5 |
| Volume | 4.25M |
| 52-week range | $15.63-$34.16 |
| RSI 14 | 54.48 |
| 50-Day SMA | $32.20 |
| 200-Day SMA | $27.43 |
| Analyst Price Target | — |
| Next Earnings | — |
CVE
Low Priority
Above Peers
Latest quote
- Momentum52
- Value57
- Quality56
- Risk resilience52
- Sentiment—
CVE Stock Analysis Summary
CVE (CVE) currently has an AIQ Score of 55/100, indicating a neutral setup. Value is the strongest factor at 57/100. Risk resilience is the weakest current factor at 52/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, CVE has AIQ Score of 55/100 with Value base of 57/100 and fading Risk resilience at 52/100. Wait for component alignment before adding exposure.
Sector · 1.87% stock move · CVE classified in its covered industry.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is CVE Bullish or Bearish Right Now?
CVE currently has a neutral overall setup. Value is the strongest factor at 57/100, while Momentum is weakest at 52/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - No strong bullish evidence is available in the current snapshot.
- - Technical consensus has more sell votes than buy votes (19 vs 16).
Current Consensus
CVE's Technical Analysis Consensus is currently Neutral, with 16 buy, 10 neutral, and 19 sell votes. CVE's 14-day RSI is 54.48, which places the stock in a neutral momentum range. CVE's beta is 0.5, indicating lower market sensitivity than the broad market.
What Changed in CVE?
The largest recent change in CVE is Momentum moving up by 6.0 points over the available 7-day comparison window. Value remains the strongest visible factor.
What Would Change the CVE Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
CVE Decision Framework
Public evidence layers, setup checks, and risk context for CVE.
CVE (CVE) Stock Analysis
CVE has an AIQ Score of 55/100 in a Neutral regime. Value is strongest at 57/100. Beta is not shown in the current snapshot. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | CVE is in a Neutral AIQ regime with score 55/100. |
| Signal Conflict | The primary conflict is that value leads at 57/100 while momentum lags at 52/100. |
| Factor Evidence | Momentum 52/100 · Value 57/100 · Quality 56/100 · Risk 52/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 57/100.
Momentum is 52/100 and RSI (14) is 54.5.
CVE is in a Neutral regime at 55/100.
Risk factor is 52/100 and annual volatility 36.31%.
Current conflict: value leads at 57/100 while momentum lags at 52/100.
CVE Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
CVE Fundamentals
CVE valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
CVE Technical Analysis
CVE technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
CVE Stock Catalysts
Track CVE earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
CVE Dividend Analysis
CVE dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
CVE Financial Data
CVE revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
CVE Risk Analysis
CVE volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
CVE Stock News
CVE stock news, market tone, recent headlines, and catalyst context.
CVE vs Oil Majors & E&P Peers
Current peer cohort: CVE · EOG · EQNR. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| CVE Current stock | — | — | — | — | 1.9 | 36.31% | Current |
| EOG EOG Resources | — | — | — | — | 1.48 | 29.14% | CVE vs EOG |
| EQNR Equinor | — | — | — | — | 1.84 | 39.10% | CVE vs EQNR |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 30, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts3 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching CVE
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for CVE
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
CVE Stock FAQ
What is CVE stock price today?
CVE's current stock price is $32.73. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is CVE bullish or bearish right now?
CVE's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is CVE's market cap?
CVE's market cap is $61.1B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is CVE's current P/E ratio?
CVE's current P/E ratio is 12.77 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is CVE's RSI?
CVE's 14-day RSI is 54.48 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is CVE above its 50-day and 200-day moving averages?
CVE is -0.23% from its 50-day SMA and 17.14% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is CVE's next earnings date?
CVE's next earnings date is a key event to check before making a decision. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does CVE pay a dividend?
CVE's dividend yield is 1.78% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.